News

Spinal cord injury (SCI) evokes profound dysfunction in hollow organs such as the urinary bladder and gut. Current treatments are limited by a lack of molecular data to inform novel therapeutic ...
Biochemical recurrence (BCR) after radical prostatectomy exhibits heterogeneous prognostic implications. Recent advancements in imaging and biomarkers have high potential for personalizing care.
Telehealth and direct-to-consumer healthcare platforms have reshaped the way patients interact with healthcare systems, especially regarding sensitive conditions such as erectile dysfunction (ED) and ...
Ambulatory Urodynamics: Improved Comfort and Diagnostic Accuracy - Jason Kim & Scott MacDiarmid ...
Histotripsy is a noninvasive, ultrasound-based tissue focused technique that uses focused high-intensity sound waves to mechanically fractionate tissue without causing thermal damage. Initially ...
Kidney-sparing endoscopic surgery is considered the preferred approach for the treatment of low-risk upper tract urothelial cancer (UTUC), yet its impact on subsequent radical nephroureterectomy's ...
Prostate-specific membrane antigen radioguided surgery (PSMA-RGS) is an emerging technique that provides real-time intraoperative guidance for identification of lymph node metastases (LNMs) in ...
Renal cell carcinoma (RCC) has a high recurrence risk, with 20-40% of patients developing metastatic disease post-nephrectomy. This study aimed to identify risk factors associated with liver and ...
Patient involvement in treatment decisions improves outcomes, but data on patients' perspectives of medical androgen deprivation therapy (ADT) options for prostate cancer are limited. This study ...
For patients with muscle-invasive bladder cancer (MIBC), time to cystectomy and receipt of neoadjuvant chemotherapy are associated with improved survival. Travel burden may be an important barrier to ...
Bladder cancer (BC) remains a significant global health concern, with substantial sex and racial disparities in incidence, progression, and outcomes. BC is the sixth most common cancer among males and ...